Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 16.0B | 15.5B | 15.3B | 14.1B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 3.8B | 3.6B | 3.6B | 3.3B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 6.7B | 6.7B | 6.4B | 6.1B |
| Tax provision | 1.6B | 1.7B | 1.6B | 1.5B |
| Net income | 5.1B | 5.0B | 4.7B | 4.6B |
| Basic EPS | — | 6.2 | 5.9 | 5.7 |
| Diluted EPS | — | 6.2 | 5.9 | 5.7 |
| Basic average shares | — | 805.2M | 804.1M | 804.6M |
| Diluted average shares | — | 805.2M | 805.4M | 804.6M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |